Fever - 131 Studies Found

Active, not recruiting : Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
: Hemorrhagic Fever, Ebola
: 2015-01-29
:
  • Biological: cAd3-EBOZ cAd3 vac
Recruiting : Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
: Ebola Hemorrhagic Fever
: 2016-09-14
: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
Recruiting : Open Study of the Duration of Immunity After Vaccination With GamEvac
: Hemorrhagic Fever, Ebola
: 2016-09-14
: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
Recruiting : Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
: Hemorrhagic Fever, Ebola
: 2015-11-04
:
  • Biological: Ad26.ZEBOV One 0.5
Recruiting : Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
: Hemorrhagic Fever, Ebola
: 2016-01-08
:
  • Biological: Ad26.ZEBOV No vacc
Withdrawn : A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
: Ebola Hemorrhagic Fever
: 2012-05-03
:
  • Drug: AVI-7537

Completed : Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
: Ebola Hemorrhagic Fever
: 2011-05-10
:
  • Drug: Placebo Normal saline
Completed : STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
: Hemorrhagic Fever, Ebola
: 2015-02-19
: Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso
Completed : Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
: Hemorrhagic Fever, Ebola
: 2014-10-31
: Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5)
Recruiting : Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
: Hemorrhagic Fever, Ebola
: 2015-09-29
:
  • Biological: Ad26.ZEBOV One 0.5
<<< Previous | Next >>>